Merus Announces Petosemtamab in Previously Treated Head and Neck Squamous Cell Carcinoma Abstract Selected for Plenary Session Oral Presentation at the AACR Annual Meeting 2023
Stocks in this Quantisnow insightHealth Care
Quantisnow market dataNASDAQ
MRUS
Merus N.V.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2016
Get push alerts for MRUS
Full MRUS profile on Quantisnow Follow MRUS and get a push notification the moment its next story breaks.